KIMBERLY JOHNSON: Open Payments
NPI 1942987144 · GREAT FALLS, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$605 in 26 payments from 8 companies in 2025. Trend: 2023 $17 · 2024 $378 · 2025 $605
Food & beverage: $605
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $238 |
| ABBVIE INC. | 12 | $179 |
| Otsuka America Pharmaceutical, Inc. | 3 | $46 |
| Amgen Inc. | 2 | $43 |
| Astellas Pharma US Inc | 1 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| PFIZER INC. | 1 | $17 |
Products named: BEVESPI AEROSPHERE, VRAYLAR, QULIPTA, REXULTI, AIRSUPRA, OTEZLA, Veozah, Kerendia.
Industry payments across MT — which companies pay providers there.
